Compare ABAT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABAT | BVS |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.6M | 482.9M |
| IPO Year | 2013 | 2016 |
| Metric | ABAT | BVS |
|---|---|---|
| Price | $3.58 | $8.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.25 |
| AVG Volume (30 Days) | ★ 3.0M | 293.3K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.14 | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $145.40 | $7.42 |
| Revenue Next Year | N/A | $6.46 |
| P/E Ratio | ★ N/A | $25.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.86 | $5.81 |
| 52 Week High | $11.49 | $11.25 |
| Indicator | ABAT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.60 | 56.72 |
| Support Level | $3.22 | $6.42 |
| Resistance Level | $3.88 | $9.01 |
| Average True Range (ATR) | 0.20 | 0.39 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 57.10 | 46.67 |
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.